Cerulean Pharma appoints new president & CEO
This article was originally published in Scrip
Cerulean Pharma, a US biopharmaceutical company developing nanoparticle-based drugs, has named Dr Oliver Fetzer president and chief executive officer. He has also been elected to the company's board of directors. Dr Fetzer succeeds Alan Crane, who has been appointed chairman. He was most recently senior vice-president of corporate development and R&D at Cubist Pharmaceuticals.